Enjoy complimentary customisation on priority with our Enterprise License!
The global sperm analytical devices market size is estimated to grow by USD 84.26 million, at a CAGR of 6.42% between 2023 and 2028.
The market is experiencing robust growth, driven by an increasing awareness of reproductive health worldwide. As societies become more informed and proactive about healthcare, there is a notable surge in individuals and couples seeking comprehensive fertility assessments. This heightened awareness is fueled by educational initiatives, public health campaigns, and the accessibility of information through various channels. Further, healthcare providers, fertility clinics, and diagnostic laboratories are responding to this awareness by integrating advanced sperm analytical devices into their services, offering precise evaluations of sperm parameters. These devices empower individuals and couples with valuable insights into their reproductive potential, reflecting a proactive approach toward reproductive health and family planning in the current informed society. Therefore, increasing awareness of reproductive health is poised to drive the growth of the market during the forecast period.
Technavio has segmented the market into End-user, Product, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the hospitals segment will be significant during the forecast period. The utilization of sperm analytical devices in hospitals has significantly transformed the landscape of reproductive healthcare. These devices, designed for comprehensive sperm analysis, have become integral tools in hospital settings, contributing to advanced diagnostics and personalized treatment plans for individuals facing fertility challenges. The controlled and sterile environments of hospitals provide an ideal setting for the precise examination of sperm parameters, such as concentration, motility, and morphology.
Get a glance at the market contribution of various segments Download PDF Sample
The hospitals segment was the largest and was valued at USD 96.38 million in 2018. The continuous advancements in sperm analytical device technology, with features like automation and enhanced data analysis capabilities, further solidify their place within hospital settings. This integration not only facilitates accurate diagnoses but also aligns with the broader trend of incorporating cutting-edge technologies into various medical specialties. As hospitals continue to prioritize comprehensive reproductive healthcare, the use of sperm analytical devices remains a driving force in enhancing the efficiency and effectiveness of fertility treatments. These factors are expected to drive the growth of the hospital segment of the market during the forecast period.
Sperm analytical devices play a crucial role in assessing male reproductive health and fertility. These devices, often referred to as sperm analyzers, utilize advanced technology to examine various parameters of sperm, providing valuable insights for both clinicians and individuals seeking to understand fertility issues. One key feature of these analyzers is their ability to assess sperm concentration, motility, and morphology. By analyzing these aspects, clinicians can evaluate the overall quality of sperm, helping to diagnose potential fertility problems. Additionally, some sperm analyzers offer features such as real-time video analysis and automatic sample processing. Real-time monitoring allows for a dynamic evaluation of sperm behavior, while automated processing streamlines the workflow for laboratory professionals. These advancements contribute to a more comprehensive understanding of male reproductive health, facilitating personalized treatment plans for couples struggling with infertility. These factors are expected to drive the growth of the analyzers segment of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
Europe is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In Europe, many factors contribute to falling fertility rates among men, such as changing lifestyles, environmental causes, and stress. Genetic factors are also considered culprits for the falling fertility rates in the continent. Another major reason for high infertility in the region is the fact that men are rarely diagnosed with the problem. This increases the chances of the couple not having a child, as in many cases, men are found to be having infertility-related issues. This, in turn, increases the demand for fertility treatment among men in the region, thereby driving the demand in Europe.
In addition, the market is expected to grow gradually during the forecast period owing to the rising standard of service provided with feasible financial charges that draw in a large number of consumers for fertility services. The market is expected to witness an increase in the number of sperm donors in the future, owing to the awareness programs being conducted in the region that will draw in a favorable number of donors toward sperm banks, in turn leading to the growth of the regional market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 13 market companies, including:
MINITUB GMBH - The company offers sperm analytical devices such as ISAS PRO which is a robotised system that automatically analyses semen quality, simultaneously assessing motility, morphology, and concentration. The robotic nature of the equipment eliminates human error and increases the objectivity of the results.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges.
Increasing demand for home-based semen analysis kits is notably driving market growth. The market is experiencing substantial growth, propelled by the increasing demand for home-based semen analysis kits. Rising awareness about reproductive health has led individuals and couples to seek more accessible and convenient ways to assess fertility parameters. Home-based semen analysis kits provide a private and user-friendly solution, allowing users to conduct basic sperm analysis in the comfort of their homes. Medical Electronic Systems, for example, offers the YO home sperm test, an FDA-approved video-based platform measuring motile sperm concentration with 97% accuracy.
Moreover, lifestyle changes, family planning delays, and a proactive approach to fertility management contribute to the growing demand for home-based solutions. Ongoing technological innovations, including smartphone app integration for result interpretation and remote consultations, further drive market growth and trends. The market is adapting to meet evolving preferences, addressing the increasing demand for accessible and self-administered fertility assessments at home. As a result, the market is poised for growth during the forecast period.
The rising number of fertility clinics is an emerging trend shaping the market growth. The awareness level among consumers has increased regarding fertility issues and solutions coupled with rising global disposable income, especially in emerging economies such as India and China. Fertility clinics, either in proximity or sharing multiple regions of operations, are expanding collective patient outreach, maintaining pricing power, and protecting quality branding by merging or partnering with each other, thereby consolidating their respective positions in the market. Over the past decade, there has been a growing level of M and A activity, particularly in APAC and Europe, including players such as Virtus Health, Monash IVF Group, and NMC Health, which have expanded geographically through acquisitions. For instance, in January 2023, Monash IVF Group acquired Pivet Medical Centre, which offers full-service fertility services.
Therefore, as clinics expand their services and leverage the technological expertise of other clinics in the market, the resultant collective entity aims at providing improved services for patients, which leads to increasing visits by patients in these clinics. Increasing visits of patients in clinics increases the demand for devices for fertility treatment. This is expected to positively impact the growth of the market during the forecast period.
Limited awareness and accessibility are significant challenges hindering the market growth for sperm quality assessment and sperm analyzer systems. The market encounters a significant hurdle in the form of limited awareness and accessibility, impeding its potential for expansive growth. In various regions, there exists a notable lack of awareness regarding the importance of male reproductive health and the availability of advanced devices for assessing sperm viability. This knowledge deficit contributes to delayed or inadequate fertility assessments, as individuals and couples may not seek out these diagnostic tools due to a lack of understanding about their significance.
Moreover, accessibility issues further compound the challenge. In certain areas, particularly in developing countries such as China and India, access to healthcare facilities and diagnostic services may be limited. The absence of a well-established reproductive health infrastructure can hinder the widespread adoption. As a consequence, individuals in these regions may face difficulties in obtaining timely and accurate assessments of male fertility. Thus, limited awareness and accessibility are expected to hinder the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
Market Analyst Overview
The advancements and increasing awareness of male reproductive health. Factors such as alcohol consumption, cigarette smoking, caffeine intake,illegal use of drug and psychological stress affect sperm quality, prompting the need for advanced analysis methods. In the Windows system segment and product type segment, innovative solutions cater to various needs, including vasectomy reversal and veterinary purposes for artificial insemination and animal breeding. These technologies assess critical parameters like sperm volume, the presence of white or red blood cells, and the percentage of immature sperms and anti-sperm antibodies, aiding in the diagnosis of male infertility.
Advanced semen analysis methods like computer-assisted semen analysis (CASA) enhance accuracy and efficiency, supporting various fertility methods such as IUI. Additionally, factors like obesity and illegal drug use impact fertility, driving the demand for comprehensive analysis.Technological advancements enable healthcare professionals to offer sophisticated services, addressing diverse needs and demographics, including fertility tourism in emerging countries. Government investments in healthcare infrastructure and reproductive technology drive market growth, despite challenges like the medical device excise tax. The human clinical in-vitro fertilization (IVF) market benefits from these advancements, promising a brighter future for male reproductive health.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
Sperm Analytical Devices Market Scope |
|
Report Coverage |
Details |
Page number |
169 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.42% |
Market Growth 2024-2028 |
USD 84.26 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
5.41 |
Regional analysis |
Europe, North America, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 34% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
MINITUB GMBH, Ongo Vettech Ltd., Sperm Analysis Tecnologies SL, The Cooper Companies Inc., Vitrolife AB, XINDRAY International Corp., Arquimea Group SA, Biola LLC, BIOLINE TECHNOLOGIES, Bonraybio, Dyneval Ltd., Hamilton Thorne Ltd., Jiangsu Sanwe Medical Science and Technology Co. Ltd., and Medical Electronic Systems |
Market dynamics |
Parent market growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.